Avanos Medical, Inc. (NYSE:AVNS – Get Free Report) was the recipient of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 681,400 shares, a drop of 6.4% from the December 15th total of 727,700 shares. Approximately 1.5% of the shares of the company are short sold. Based on an average trading volume of 349,300 shares, the short-interest ratio is currently 2.0 days.
Avanos Medical Trading Down 0.7 %
NYSE AVNS traded down $0.11 during trading on Friday, hitting $15.94. 290,991 shares of the company’s stock traded hands, compared to its average volume of 429,124. The stock has a fifty day moving average of $17.42 and a two-hundred day moving average of $20.79. Avanos Medical has a 12-month low of $14.98 and a 12-month high of $25.36. The firm has a market cap of $732.60 million, a P/E ratio of 46.88 and a beta of 0.99. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of AVNS. Quarry LP purchased a new stake in Avanos Medical in the third quarter worth about $42,000. KBC Group NV lifted its stake in shares of Avanos Medical by 63.0% in the 3rd quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after purchasing an additional 1,095 shares during the period. Canada Pension Plan Investment Board purchased a new position in shares of Avanos Medical in the 2nd quarter valued at approximately $70,000. Intech Investment Management LLC purchased a new stake in Avanos Medical in the third quarter worth $207,000. Finally, Atom Investors LP bought a new position in Avanos Medical in the third quarter worth $210,000. Hedge funds and other institutional investors own 95.17% of the company’s stock.
Analysts Set New Price Targets
Read Our Latest Stock Report on Avanos Medical
About Avanos Medical
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Articles
- Five stocks we like better than Avanos Medical
- Short Selling – The Pros and Cons
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- How to Invest in Insurance Companies: A GuideĀ
- Oilfield Leader SLB: An AI Name You Need to Know
- Where to Find Earnings Call Transcripts
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.